Antares Therapeutics
Boston
About Antares Therapeutics
Antares Therapeutics is a biotechnology company focused on developing transformational precision medicines targeting validated but previously undruggable targets in cancer and other serious diseases with significant unmet medical needs. Founded as a spin-out from Scorpion Therapeutics, it leverages proprietary drug discovery capabilities and a robust preclinical pipeline to advance multiple programs, primarily in precision oncology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $177.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2025)
- Website: antaresrx.com
- Phone: +1 781-288-5760
Industries & Categories
Biopharma, Biotechnology, Ediscovery, Health Care, Life Science
Social Profiles
Canonical: https://fsome.com/organization/antares-therapeutics-11248 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.